These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16401668

  • 1. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems.
    Tachibana K, Matsumoto M, Koseki H, Togashi H, Kojima T, Morimoto Y, Yoshioka M.
    J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668
    [Abstract] [Full Text] [Related]

  • 2. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.
    Tachibana K, Matsumoto M, Togashi H, Kojima T, Morimoto Y, Kemmotsu O, Yoshioka M.
    Neurosci Lett; 2004 Mar 04; 357(2):91-4. PubMed ID: 15036582
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N.
    Psychopharmacology (Berl); 2002 Jul 04; 162(3):323-32. PubMed ID: 12122491
    [Abstract] [Full Text] [Related]

  • 4. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T, Hayashi M, Ino K, Takada S, Ushizawa D, Hoshi K.
    Eur Neuropsychopharmacol; 2004 Dec 04; 14(6):471-8. PubMed ID: 15589386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.
    Ohnami S, Kato A, Ogawa K, Shinohara S, Ono H, Tanabe M.
    Br J Pharmacol; 2012 Oct 04; 167(3):537-47. PubMed ID: 22537101
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
    Weiss M, Blier P, de Montigny C.
    Life Sci; 2007 Jun 20; 81(2):166-76. PubMed ID: 17568622
    [Abstract] [Full Text] [Related]

  • 9. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
    Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T, Kaneko S.
    Int J Neuropsychopharmacol; 2013 Nov 20; 16(10):2295-306. PubMed ID: 23920436
    [Abstract] [Full Text] [Related]

  • 10. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
    Cooke JD, Cavender HM, Lima HK, Grover LM.
    Psychopharmacology (Berl); 2014 Dec 20; 231(23):4429-41. PubMed ID: 24781518
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
    Bel N, Artigas F.
    Neuropsychopharmacology; 1999 Dec 20; 21(6):745-54. PubMed ID: 10633480
    [Abstract] [Full Text] [Related]

  • 12. Preclinical pharmacology of milnacipran.
    Briley M, Prost JF, Moret C.
    Int Clin Psychopharmacol; 1996 Sep 20; 11 Suppl 4():9-14. PubMed ID: 8923122
    [Abstract] [Full Text] [Related]

  • 13. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
    Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Tanaka T, Masui T, Koyama T.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):285-90. PubMed ID: 18336812
    [Abstract] [Full Text] [Related]

  • 14. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP.
    Neuropharmacology; 2003 Dec 28; 45(7):935-44. PubMed ID: 14573386
    [Abstract] [Full Text] [Related]

  • 15. Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine.
    Ohashi S, Matsumoto M, Otani H, Mori K, Togashi H, Ueno K, Kaku A, Yoshioka M.
    Brain Res; 2002 Sep 13; 949(1-2):131-8. PubMed ID: 12213308
    [Abstract] [Full Text] [Related]

  • 16. Supraspinal Projection of Serotonergic and Noradrenergic Pathways Modulates Nociceptive Transmission in the Lower Urinary Tract of Rats.
    Mitsui T, Kanno Y, Kitta T, Moriya K, Nonomura K.
    Low Urin Tract Symptoms; 2016 Sep 13; 8(3):186-90. PubMed ID: 27619785
    [Abstract] [Full Text] [Related]

  • 17. Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
    Moret C, Briley M.
    J Neurochem; 1997 Aug 13; 69(2):815-22. PubMed ID: 9231743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of milnacipran on the inhibitory postsynaptic potential in neurons of the rat locus coeruleus.
    Kuwahata T, Kidani Y, Ishimatsu M, Akasu T.
    Kurume Med J; 2004 Aug 13; 51(3-4):185-91. PubMed ID: 15682825
    [Abstract] [Full Text] [Related]

  • 20. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
    Muneoka K, Kuwagata M, Ogawa T, Shioda S.
    Neuroreport; 2015 Jun 17; 26(9):510-4. PubMed ID: 26016648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.